Trial site
University Clinical Hospital Virgen De La Arrixaca
- 217running trials
- 66closed trials
The trials here
What the 284 trials at this site are about, from their registry records.
- Conditions
- Multiple myeloma25 trials
- Childhood cancers22 trials
- Metastatic breast cancer22 trials
- Multiple sclerosis21 trials
- Heart failure19 trials
- Melanoma18 trials
- Lung cancer12 trials
- Ovarian cancer11 trials
- Stroke11 trials
- Prostate cancer9 trials
- Acute myeloid leukaemia8 trials
- Hypertrophic cardiomyopathy8 trials
- and 49 more
- Phase
- Phase 3159 trials
- Phase 280 trials
- Phase 1/215 trials
- Phase 412 trials
- Phase 2/310 trials
- Phase 18 trials
- Status
- Recruiting106 trials
- Active, not recruiting84 trials
- Completed66 trials
- Not yet recruiting27 trials
- Suspended1 trial
- Lead sponsor
- Novartis Pharmaceuticals12 trials
- Regeneron Pharmaceuticals11 trials
- Fundacion Para La Formacion E Investigacion Sanitaria De La Region De Murcia8 trials
- Hoffmann-La Roche8 trials
- Novo Nordisk A/S7 trials
- and 159 more
Running trials
Not yet recruiting
Not yet recruiting
Recruiting
Not yet recruiting
Not yet recruiting
Not yet recruiting
Recruiting
A Research Study Investigating Denecimig (Mim8) in Adults With Acquired Haemophilia A
Recruiting
Not yet recruiting
Recruiting
Recruiting
Recruiting
Not yet recruiting
Recruiting
Recruiting
Recruiting
Recruiting
Stroke and Systemic Embolism Prevention in Adult Participants With Atrial Fibrillation
Recruiting
Recruiting
A Study of ASP2138 Together With Chemotherapy and Pembrolizumab in Adults With Gastric Cancer
Recruiting
Recruiting
Recruiting
Not yet recruiting
Optimizing the Use of Aspirin for the Prevention of Preeclampsia
Not yet recruiting
Not yet recruiting
Active, not recruiting
Study of an On-Body Injection System for Home Use of Ocrelizumab in People with Multiple Sclerosis
Recruiting
Recruiting
Recruiting
A Phase 3 Study of Pelabresib (DAK539) and Ruxolitinib in Myelofibrosis (MF)
Recruiting
Recruiting
Recruiting
Recruiting
Recruiting
ROCKET-CLL Global Phase 3 Study: Rocbrutinib vs Pirtobrutinib in cBTKi-Pretreated R/R CLL/SLL
Recruiting
Recruiting
Recruiting
Recruiting
Recruiting
Recruiting
A Study of Orelabrutinib in Patients With Secondary Progressive Multiple Sclerosis
Recruiting
A Study of Orelabrutinib in Patients With Primary Progressive Multiple Sclerosis
Recruiting
Active, not recruiting
Recruiting
Recruiting
Recruiting
Recruiting
Recruiting
Recruiting
Evaluation of Novel Thrombolytic TGD001 in Patients With Acute Ischemic Stroke
Recruiting
Showing 50 of 217.
Recruiting at the same time
How many trials recruit for the same indication here at once. A count, not a rating.
- Childhood cancers14 recruiting
- Multiple myeloma11 recruiting
- Heart failure8 recruiting
- Ovarian cancer8 recruiting
- Acute myeloid leukaemia7 recruiting
- Metastatic breast cancer7 recruiting
- Melanoma6 recruiting
- Multiple sclerosis6 recruiting
- Acute lymphoblastic leukaemia4 recruiting
- Chronic lymphocytic leukaemia4 recruiting
- Dilated cardiomyopathy4 recruiting
- Lung cancer4 recruiting
- Obesity4 recruiting
- Prostate cancer4 recruiting
- Stroke4 recruiting
- Triple-negative breast cancer4 recruiting
- Brain metastases3 recruiting
- Endometrial cancer3 recruiting
- Follicular lymphoma3 recruiting
- Haemophilia3 recruiting
- Lupus (SLE)3 recruiting
- Myelodysplastic syndromes3 recruiting
- Amyloidosis2 recruiting
- Aortic stenosis2 recruiting
- Atrial fibrillation2 recruiting
- Bladder cancer2 recruiting
- Chronic myeloid leukaemia2 recruiting
- Colorectal cancer2 recruiting
- Coronary artery disease2 recruiting
- Deep vein thrombosis and pulmonary embolism2 recruiting
- Gastric and oesophageal cancer2 recruiting
- Hypertrophic cardiomyopathy2 recruiting
- Myasthenia gravis2 recruiting
- Myeloproliferative neoplasms2 recruiting
- ALS (motor neurone disease)1 recruiting
- Ankylosing spondylitis1 recruiting
- Asthma1 recruiting
- Cervical cancer1 recruiting
- Chronic kidney disease1 recruiting
- Cystic fibrosis1 recruiting
- Diffuse large B-cell lymphoma1 recruiting
- High blood pressure1 recruiting
- Hodgkin lymphoma1 recruiting
- Idiopathic pulmonary fibrosis1 recruiting
- IgA nephropathy1 recruiting
- Immune thrombocytopenia (ITP)1 recruiting
- Kidney cancer1 recruiting
- Liver and biliary tract cancer1 recruiting
- Myocarditis1 recruiting
- Pancreatic cancer1 recruiting
- Peripheral artery disease1 recruiting
- Psoriasis1 recruiting
- Psoriatic arthritis1 recruiting
- Rheumatoid arthritis1 recruiting
- Sarcoma1 recruiting
- Type 2 diabetes1 recruiting
Closed trials
Completed
Completed
Completed
Completed
Phase 2b Randomized, Double-Blind Study with Phage for CF Subjects with Pseudomonas Lung Infection
Completed
Completed
Completed
Completed
Active, not recruiting
Completed
A proof of concept and dose-finding study of XXB750 in patients with heart failure
Completed
Completed
Completed
Active, not recruiting
Completed
Completed
Completed
Completed
Completed
Active, not recruiting
Active, not recruiting
Completed
Completed
Completed
Completed
Active, not recruiting
Completed
Completed
Completed
A Study of Milvexian in Participants After a Recent Acute Coronary Syndrome
Completed
Terminated
Completed
Completed
Completed
Completed
Completed
Completed
Completed
Recruiting
Study of Nab-Paclitaxel and Gemcitabine With or Without SBP-101 in Pancreatic Cancer
Completed
Completed
Completed
Advanced hormone receptor-positive/HER2-negative/HER2-Enriched breast cancer
Completed
Completed
Completed
Completed
Completed
Completed
Completed
Completed
Showing 50 of 66.
Site data: ClinicalTrials.govUpdated 18 Nov 2026